Synviscone.com
Official pharmaceutical site from Genzyme Corporation. Includes consumer and professional information.
Global Traffic Rank
Rank in the United States
Safety/Trust
Child Safety
Registered
Visitors / Day*
Pageviews / Day*
Website Worth*
Revenue / Day*
About Synviscone.com
The domain Synviscone.com belongs to the generic Top-level domain .com. It is associated with the IPv4 address 54.247.151.159. The domain has been registered 17 years ago with CSC Corporate Domains, Inc. on Apr 2007. The site has its servers located in Ireland.
Trace an Email Address
Synviscone.com Server Location
Unveil the Server Location - Explore Where the Website's Servers are Physically Hosted!
Ireland
Synviscone.com Website Information
Uncover the website's purpose and content, complemented by relevant focus keywords.
Website Summary
Synvisc-One : Official pharmaceutical site from Genzyme Corporation. Includes consumer and professional information
Main Language
n/a
Inbound Links
117
Synviscone.com Web Server
Discover essential Web Server Information: server software, page load time, and website language at your fingertips!
Webserver Software
Median Page Load Time
Synviscone.com WHOIS Data
Discover comprehensive domain registration details and more with the accessible Whois data information right here!
Domain Registered
Domain Updated
Domain Expiry
WHOIS Server
Domain Status
Nameservers
DNSSEC
Synviscone.com DNS Resource Records
Unlock the full potential of the domain with a comprehensive review of its DNS configuration, including SOA, A, AAAA, MX, NS, and TXT records.
A Records
@ IN A 54.247.151.159
AAAA Records
No AAAA records could be found.
MX Records
No MX records could be found.
NS Records
@ IN NS ns1.sanofi-synthelabo.com
@ IN NS ns2.sanofi-synthelabo.com
@ IN NS ns3.sanofi-synthelabo.com
@ IN NS ns4.sanofi-synthelabo.com
TXT Records
@ IN TXT "facebook-domain-verification=8css941sswwtjzq6g8225wot6dremm"
SOA Record
@ IN SOA ns1.sanofi-synthelabo.com. gtly-domtech.sanofi.com
(
2016030792 ; serial
28800 ; refresh (8 hours)
14400 ; retry (4 hours)
3600000 ; expire (41 days, 16 hours)
900 ; minimum (15 minutes)
)
Similar Domain Names like Synviscone.com
Websites with similar domain names, indicating related or similar web addresses.
Related Keywords
Explore related keywords for the domain name in search engines.
- synviscone dot com
- synviscone com
- http //synviscone.com
- https //synviscone.com
Synviscone com Frequently Asked Questions (FAQ)
Unveiling the Most Asked Questions - Synviscone.com Demystified!
Is the site safe, legit and trustworthy?
Currently we have not enough information to determine whether the site is safe, legit or trustworthy.
Is the site safe for children?
Currently we have not enough information to determine whether the site is safe for kids or not.
What is the domain about?
Official pharmaceutical site from Genzyme Corporation. Includes consumer and professional information.
Who is the registrar for the domain?
The domain has been registered at CSC Corporate Domains, Inc. You can visit the registrar's website at http://cscdbs.com. The registrar's WHOIS server can be reached at whois.corporatedomains.com.
What is the IP address?
The hostname resolves to the IPv4 address 54.247.151.159.
When did the domain come out?
The domain was registered 6225 days ago on Tuesday, April 3, 2007.
When has the domain expired?
This domain has expired 15 days ago on Wednesday, April 3, 2024.
When was the last WHOIS update?
The WHOIS entry was last updated 751 days ago on Wednesday, March 30, 2022.
What are the domain's nameservers?
DNS is provided by the following nameservers:
- ns1.sanofi-synthelabo.com
- ns2.sanofi-synthelabo.com
- ns3.sanofi-synthelabo.com
- ns4.sanofi-synthelabo.com
How many people visit the site each day?
The site receives approximately 1.2 Thousand visitors and 2 Thousand page impressions per day.
From which countries does the website receive most of its visitors from?
The site is mostly visited by people located in the United States and .
Where are the server locations?
The site has its servers located in Ireland.